Systolic hypertension; alpha blockers and prostatism; are beta blockers still indicated; diabetes, obesity, and hypertension -- comments on the JCH contents.
Moser
M
M
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D009765:Obesity / Q000188:drug therapy*; D011470:Prostatic Hyperplasia / Q000209:etiology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists